A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Phase
3Span
148 weeksSponsor
Eli Lilly and CompanyKisarazu, Chiba
Recruiting
A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Phase
3Span
106 weeksSponsor
TakedaKisarazu, Chiba
Recruiting
1-2 of 2